Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Brain function and blood flow

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Full-Length Open Reading Frame Amplification of Hepatitis C Virus

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

An effective vaccine to the antigenically diverse hepatitis C virus (HCV) must target conserved immune epitopes. Here, we investigate cross-neutralization of HCV genotypes by broadly neutralizing antibodies (bNAbs) encoded by the relatively abundant human gene family V H 1-69. We have deciphered the molecular requirements for cross-neutralization by this unique class of human antibodies from crystal structures of HCV E2 in complex with bNAbs. An unusually high binding affinity is found for germ line-reverted versions of VH1-69 precursor antibodies, and neutralization breadth is acquired during affinity maturation. Deep sequencing analysis of an HCV-immune B cell repertoire further demonstrates the importance of the V H 1-69 gene family in the generation of HCV bNAbs. This study therefore provides critical insights into immune recognition of HCV with important implications for rational vaccine design.

Original languageEnglish
Article numbereaav1882
JournalScientific American
Volume5
Issue number1
Pages (from-to)eaav1882
ISSN0036-8733
DOIs
Publication statusPublished - 1 Jan 2019

ID: 56115344